Paul R Leger

Years Active: 2020-2022
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Jeffrey J Jackson, Grant M Shibuya, Buvana Ravishankar, Lavanya Adusumilli, Delia Bradford, Dirk G Brockstedt, Cyril Bucher, Minna Bui, Cynthia Cho, Christoph Colas, Gene Cutler, Adrian Dukes, Xinping Han, Dennis X Hu, Scott Jacobson, Paul D Kassner, George E Katibah, Michelle Yoo Min Ko, Urvi Kolhatkar, Paul R Leger, Anqi Ma, Lisa Marshall, Jack Maung, Andrew A Ng, Akinori Okano, Deepa Pookot, Daniel Poon, Chandru Ramana, Maureen K Reilly, Omar Robles, Jacob B Schwarz, Anton A Shakhmin, Hunter P Shunatona, Raashi Sreenivasan, Parcharee Tivitmahaisoon, Mengshu Xu, Thant Zaw, David J Wustrow, Mikhail Zibinsky
Potent GCN2 Inhibitor Capable of Reversing MDSC-Driven T Cell Suppression Demonstrates In Vivo Efficacy as a Single Agent and in Combination with Anti-Angiogenesis Therapy. Journal of medicinal chemistry 65 (19) (2022)
Paul R Leger, Dennis X Hu, Berenger Biannic, Minna Bui, Xinping Han, Emily Karbarz, Jack Maung, Akinori Okano, Maksim Osipov, Grant M Shibuya, Kyle Young, Christopher Higgs, Betty Abraham, Delia Bradford, Cynthia Cho, Christophe Colas, Scott Jacobson, Yamini M Ohol, Deepa Pookot, Payal Rana, Jerick Sanchez, Niket Shah, Michael Sun, Steve Wong, Dirk G Brockstedt, Paul D Kassner, Jacob B Schwarz, David J Wustrow
Discovery of Potent, Selective, and Orally Bioavailable Inhibitors of USP7 with In Vivo Antitumor Activity. Journal of medicinal chemistry 63 (10) (2020)

Paul R Leger.css-eqlu8i{font-size:small;padding-left:4px;}